Introducing GPT-Rosalind for life sciences research
OpenAI unveiled GPT-Rosalind, a specialized reasoning model designed to enhance drug discovery, genomics analysis, and protein research workflows in life sciences. The model targets scientific researchers seeking to accelerate computational biology and pharmaceutical development pipelines.
MentionsOpenAI · GPT-Rosalind
Read full story at OpenAI →(openai.com)
Modelwire summarizes — we don’t republish. The full article lives on openai.com. If you’re a publisher and want a different summarization policy for your work, see our takedown page.